Joel Reiss, Co-Chief Operating Officer of TransDigm Group Inc, filed a Form 4 on September 16, 2026, disclosing the exercise of stock options and the subsequent sale of common stock on September 15, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Option exercise: Reiss exercised 3,900 stock options at an exercise price of $284.97 per share, acquiring 3,900 shares of common stock via transaction code M.
  • Shares sold: A total of 3,900 shares were disposed of across multiple sale transactions on September 15, 2026, at weighted average prices ranging from approximately $1,082.36 to $1,118.995 per share.
  • Remaining direct ownership: Following all reported transactions, Reiss beneficially owned 3,600 shares of common stock directly.
  • Remaining options: Reiss retained 4,100 stock options with an exercise price of $284.97, expiring November 8, 2027.
  • Rule 10b5-1 plan: The filing indicates the transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  • Issuer: TransDigm Group Inc, traded on NYSE:TDG.

Joel Reiss Option Exercise and Share Sales at TransDigm Group

According to the Form 4 filed with the SEC, Joel Reiss, serving as Co-Chief Operating Officer of TransDigm Group Inc (NYSE:TDG), executed a series of transactions on September 15, 2026. The filing shows Reiss first acquired 3,900 shares of common stock through the exercise of stock options at a conversion price of $284.97 per share (transaction code M). Prior to the exercise, Reiss held 7,500 shares directly; following the acquisition, that figure rose to 7,500 shares as reported in the filing sequence.

Reiss then sold all 3,900 acquired shares across 27 separate sale transactions (transaction code S) on the same date, September 15, 2026. The filing reports each sale at a weighted average price, with individual transaction prices ranging from $1,082.3500 to the highest reported weighted average of $1,118.995. According to the filing, the reported prices represent weighted averages, and Reiss "undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price." After all sales, Reiss directly owned 3,600 shares of common stock.

In Table II of the filing, Reiss retained 4,100 stock options at an exercise price of $284.97, with an expiration date of November 8, 2027. The filing notes the option became exercisable on September 30, 2021. The filing also confirms that all transactions were conducted under a Rule 10b5-1(c) trading plan, as indicated by the checked box on the form cover.

What Was Disclosed

The filing disclosed a same-day option exercise and share sale by TransDigm Group's Co-Chief Operating Officer on September 15, 2026, resulting in direct beneficial ownership of 3,600 common shares and 4,100 remaining stock options.